RMHIOTCPharmaceutical PreparationsFiscal year ends September 30

Retrieve Medical Holdings, Inc.

Financials through Q1 FY2023, quarter ended Dec 31, 2022Last filing: 10-Q on Feb 9, 2023

$0.85+0.01 (+1.78%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Retrieve Medical Holdings, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30	FY 2018 2018-09-30	FY 2017 2017-09-30	FY 2016 2016-09-30	FY 2015 2015-09-30	FY 2014 2014-09-30	FY 2013 2013-09-30	FY 2012 2012-09-30	FY 2011 2011-09-30	FY 2010 2010-09-30	FY 2009 2009-09-30
Research & Development	–	–	–	–	–	–	–	0.01	0.03	–	–	–	–	–
Selling, General & Admin	–	–	–	–	–	0.02	0.02	–	–	–	–	–	–	–
General & Administrative	0.16	0.07	0.01	0.01	0.03	0.04	0.19	0.46	2.67	0.01	0.02	0.02	0.02	–
Advertising Expenses	–	–	–	–	–	–	–	–	-0.04	–	–	–	–	–
Operating Expenses	0.16	0.07	0.01	0.01	0.03	0.04	-1.09	2.34	3.09	0.01	–	0.02	0.02	–
Operating Income	-0.16	-0.07	-0.01	-0.01	-0.03	-0.04	1.09	-2.34	–	–	–	–	–	–
Interest Expense	0.03	0.01	0.01	0.01	0.01	0.00	0	0.00	-0.70	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0.08	–	–	–	–	–	–	–
Pretax Income	–	–	–	–	–	–	–	–	–	-0.01	-0.02	-0.02	–	–
Income Tax Expense	–	–	–	–	–	–	0	0	–	–	–	–	–	–
Income from Continuing Operations	–	–	–	–	–	-0.05	1.09	-2.34	-3.09	-0.01	–	–	–	–
Income from Discontinued Operations	–	–	–	–	–	–	0.07	0.03	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	-0.01	-0.02	-0.02	-0.02	–
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	-0.01	-0.02	-0.02	-0.02	-0.02
Net Income	-0.16	-0.08	-0.02	-0.01	-0.03	-0.05	1.16	-2.31	-3.76	-0.01	-0.02	-0.02	-0.02	-0.02
EPS (Basic)(per share)	–	0.00	0.00	0.00	0.00	0.00	–	–	–	0.00	0.00	0.00	-0.0001	–
EPS (Diluted)(per share)	–	0.00	0.00	0.00	0.00	0.00	–	–	–	–	–	0.00	-0.0001	–
Shares Outstanding (Basic, Weighted)(shares)	–	78	78	78	78	78	78	78	75	331	331	331	328	–
Shares Outstanding (Diluted, Weighted)(shares)	–	78	78	78	78	78	81	78	75	331	331	331	328	–
EBITDA	–	–	–	–	–	–	1.11	-2.33	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2022

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2022: 40.4%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –